A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

التفاصيل البيبلوغرافية
العنوان:	A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
المؤلفون:	Gruber, A, Bjorkholm, M, Brinch, L, Evensen, S, Gustavsson, B, Hedenus, M, Juliusson, G, Lofvenberg, E, Nesthus, I, Simonsson, B, Sjo, M, Stenke, L, Tangen, JM, Tidefelt, U, Uden, AM, Paul, C, Liliemark, J
المصدر:	Leukemia research. 27(4):323-328
مصطلحات موضوعية:	Medicin och hälsovetenskap
URL الوصول:	http://kipublications.ki.se/Default.aspx?queryparsed=id:1932847
قاعدة البيانات:	SwePub

الوصف
تدمد:	01452126
DOI:	10.1016/S0145-2126(02)00181-9